Why the study?
Do apolipoprotein concentrations in ovarian cyst fluids discriminate malignant from benign and borderline ovarian tumors?
Do apolipoprotein concentrations in ovarian cyst fluids discriminate malignant from benign and borderline ovarian tumors?
Apolipoproteins A2 and E in ovarian cyst fluids show high specificity and accuracy for identifying malignant ovarian tumors, suggesting dysregulated lipoprotein metabolism in ovarian cancer.
May aid ovarian tumor classification via cyst fluid analysis; leaves open prospective validation before clinical adoption.
SELDI-TOF MS analysis of ovarian cyst fluids revealed that peaks m/z 8696 and 8825 discriminate malignant, borderline, and benign tumors. These peaks correspond to isoforms of apoA2. ELISA demonstrates that apoA1, A2, B, C2, C3, and E cyst fluid concentrations are uncorrelated and higher in malignant ovarian tumors, but only apoA2, apoE, and age are independent classifiers of malignant ovarian tumors, yielding 55.1% sensitivity, 95% specificity, and 88.1% accuracy to discern malignant from benign and borderline tumors. These data suggest that lipoprotein metabolism is dysregulated in ovarian cancer and that apoA2 and apoE warrant further investigation as ovarian tumor biomarkers.
No takes yet. Share an insight, caveat, or question.
Podzielinski et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Cancer Investigation